From November 7, 2023 to November 8, 2023, the company has repurchased 1,924,600 shares, representing 2.53% for ¥11,999.88 million. With this, the company has completed the repurchase of 1,924,600 shares, representing 2.53% for ¥11,999.88 million under the buyback announced on November 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,601 JPY | +0.66% | +1.98% | -17.51% |
Mar. 31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Mar. 30 | Kobayashi factory searched over deaths possibly linked to supplements | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.51% | 2.66B | |
+14.16% | 396B | |
+12.87% | 143B | |
+18.21% | 77.23B | |
-12.61% | 65.65B | |
-9.18% | 48.32B | |
-6.18% | 39.2B | |
+6.82% | 35.21B | |
+11.68% | 18.31B | |
+14.87% | 15.95B |
- Stock Market
- Equities
- 4967 Stock
- News Kobayashi Pharmaceutical Co., Ltd.
- Tranche Update on Kobayashi Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 7, 2023.